BRIDGEWATER, N.J.--(BUSINESS WIRE)--Asana BioSciences, LLC (“Asana,” www.asanabio.com), an independent member of the Amneal Alliance of Companies, has acquired the early stage branded pharmaceutical discovery platform of Endo Pharmaceuticals, a subsidiary of Endo International plc. Asana is a research and development company specializing in the discovery and development of new chemical and biological entities. The company’s portfolio consists of multiple compounds for oncology and pain indications that are ready to enter clinical trials. Asana is based in Bridgewater, NJ and led by Dr. Sandeep Gupta, Chief Executive Officer, who, until recently, was the Senior Vice President of Discovery and Early Development at Endo Pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.
